E-LIB Suche - Ergebnisse für: Reungwetwattana, Thanyanan

1

Healthcare coverage affects survival of EGFR-mutant Thai lu..:

Khiewngam, Khantong ; Oranratnachai, Songporn ; Kamprerasart, Kaettipong...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell L..:

Popat, Sanjay ; Ahn, Myung-Ju ; Ekman, Simon...
Targeted Oncology. 18 (2023) 2 - p. 311-311 , 2023

Link: https://doi.org/10.1007/..

3

Expert Consensus Recommendations on Biomarker Testing in Me..:

Mitsudomi, Tetsuya ; Tan, Daniel ; Yang, James Chih-Hsin...
Journal of Thoracic Oncology. 18 (2023) 4 - p. 436-446 , 2023

Link: https://doi.org/10.1016/..

4

CYP450 and drug efflux transporters polymorphism influence ..:

Majam, Teerapat ; Sukasem, Chonlaphat ; Reungwetwattana, Thanyanan...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

A Phase II Study of Osimertinib in Patients with Advanced-S..:

Ang, Yvonne L. E. ; Zhao, Xiaotian ; Reungwetwattana, Thanyanan...
Cancers. 15 (2023) 20 - p. 4999 , 2023

Link: https://doi.org/10.3390/..

6

Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in T..:

Reungwetwattana, Thanyanan ; Cho, Byoung Chul ; Lee, Ki Hyeong...
Journal of Thoracic Oncology. 18 (2023) 10 - p. 1351-1361 , 2023

Link: https://doi.org/10.1016/..

7

Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Cent..:

Popat, Sanjay ; Ahn, Myung-Ju ; Ekman, Simon...
Targeted Oncology. 18 (2023) 1 - p. 9-24 , 2023

Link: https://doi.org/10.1007/..

8

Asian Thoracic Oncology Research Group (ATORG) Expert Conse..:

Ahn, Myung-Ju ; Mendoza, Marvin Jonne L. ; Pavlakis, Nick...
Clinical Lung Cancer. 23 (2022) 8 - p. 670-685 , 2022

Link: https://doi.org/10.1016/..

9

Gastrointestinal microbiota profile and clinical correlatio..:

Saifon, Woraseth ; Sensorn, Insee ; Trachu, Narumol...
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

10

Effects of polymorphisms in the MTHFR gene on 5-FU hematolo..:

Atasilp, Chalirmporn ; Lenavat, Rinradee ; Vanwong, Natchaya...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

11

Efficacy of Combination Docetaxel and Nintedanib in Advance..:

Korphaisarn, Krittiya ; Danchaivijitr, Pongwut ; Reungwetwattana, Thanyanan...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

12

Dacomitinib as first-line treatment for EGFR mutation-posit..:

Reungwetwattana, Thanyanan ; Rohatgi, Nitesh ; Mok, Tony S..
Expert Review of Precision Medicine and Drug Development. 6 (2021) 3 - p. 161-171 , 2021

Link: https://doi.org/10.1080/..

13

Efficacy of First Line Systemic Chemotherapy and Multikinas..:

Oranratnachai, Songporn ; Rattanasiri, Sasivimol ; Pooprasert, Anantaporn...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

14

An International Real-World Analysis of the Efficacy and Sa..:

Zhu, Viola W. ; Lin, Yen-Ting ; Kim, Dong-Wan...
Journal of Thoracic Oncology. 15 (2020) 9 - p. 1484-1496 , 2020

Link: https://doi.org/10.1016/..

15

Economic evaluation of adjuvant trastuzumab therapy for HER..:

Genuino, Anne Julienne ; Gloria, Mac Ardy Junio ; Chaikledkaew, Usa..
Expert Review of Pharmacoeconomics & Outcomes Research. 21 (2020) 5 - p. 1001-1010 , 2020

Link: https://doi.org/10.1080/..